Malassezia Spp
Mostrando 25-35 de 35 artigos, teses e dissertações.
-
25. AVALIAÇÃO DO POTENCIAL ANTIFÚNGICO DE ÓLEOS ESSENCIAIS DE PLANTAS DO NORDESTE BRASILEIRO FRENTE A DIFERENTES CEPAS DE MICROSPORUM CANIS, CANDIDA SPP E MALASSEZIA PACHYDERMATIS
Mycoses are serious public health concern specially in subtropical and tropical regions with dermatophytes and yeast infections being the most common pathogens. This work was undertaken in order to test whether essential oils extracted from the leaves of Croton species (Croton nepetaefolius, Croton argyrophylloides and Croton zehntneri) or from Lippia sidoid
Publicado em: 2005
-
26. IdentificaÃÃo de espÃcies de Malassezia em pacientes com pitirÃase versicolor atendidos no ambulatÃrio de dermatologia em JoÃo Pessoa - PB
A PitirÃase Versicolor (PV) Ã o distÃrbio de pigmentaÃÃo cutÃnea mais freqÃente no mundo. Apresenta tendÃncia a cronicidade e recidiva o que compromete a efetividade do tratamento. Atualmente, sÃo reconhecidas sete espÃcies de Malassezia: M. furfur, M. sympodialis, M. globosa, M. obtusa, M. restricta, M. slooffiae e M. pachydermatis. Dessas, as sei
Publicado em: 2004
-
27. Evaluation of Different Preservation and Storage Methods for Malassezia spp.
Freezing at −80°C, lyophilization, preservation in distilled water, and storage in different culture media were performed in order to find a suitable method that allowed a prolonged storage of Malassezia spp. Freezing at −80°C was the only method successful at maintaining all species.
American Society for Microbiology.
-
28. Association of Malassezia pachydermatis with systemic infections of humans.
Thirty-two Malassezia spp. isolates from human clinical specimens represented M. furfur and M. pachydermatis. Both species reportedly were obtained from patients with similar febrile systemic syndromes, including infections of the lungs or other tissues.
-
29. In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638
R126638 is a new triazole agent with potent antifungal activity in vitro against various dermatophytes, Candida spp., and Malassezia spp. Its activity against Malassezia spp. in vitro was superior to that of ketoconazole, the agent currently used for the treatment of Malassezia-related infections. R126638 showed activity comparable to or lower than that of i
American Society for Microbiology.
-
30. Human infections due to Malassezia spp.
The genus Malassezia contains three member species: Malassezia furfur and Malassezia sympodialis, both obligatory lipophilic, skin flora yeasts of humans, and Malassezia pachydermatis, a nonobligatory lipophilic, skin flora yeast of other warm-blooded animals. Several characteristics suggest the basidiomycetous nature of these yeasts, although a perfect stag
-
31. Molecular Analysis of Malassezia Microflora on the Skin of Atopic Dermatitis Patients and Healthy Subjects
Members of the genus Malassezia, lipophilic yeasts, are considered to be one of the exacerbating factors in atopic dermatitis (AD). We examined variation in cutaneous colonization by Malassezia species in AD patients and compared it with variation in healthy subjects. Samples were collected by applying transparent dressings to the skin lesions of AD patients
American Society for Microbiology.
-
32. In Vitro Susceptibilities of Malassezia Species to a New Triazole, Albaconazole (UR-9825), and Other Antifungal Compounds
The in vitro activity of the new triazole albaconazole (UR-9825) in comparison with those of flucytosine, fluconazole, ketoconazole, itraconazole, and voriconazole against 70 strains of Malassezia spp. was determined by a microdilution method using a colorimetric indicator for metabolic activity. Albaconazole showed an in vitro profile similar to those of th
American Society for Microbiology.
-
33. In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184.
A new pradimicin derivative, BMS-181184, was compared with amphotericin B and fluconazole against 249 strains from 35 fungal species to determine its antifungal spectrum. Antifungal testing was performed by the broth macrodilution reference method recommended by the National Committee for Clinical Laboratory Standards (document M27-P, 1992). BMS-181184 MICs
-
34. The Novel Azole R126638 Is a Selective Inhibitor of Ergosterol Synthesis in Candida albicans, Trichophyton spp., and Microsporum canis
R126638 is a novel triazole with in vitro activity similar to that of itraconazole against dermatophytes, Candida spp., and Malassezia spp. In animal models of dermatophyte infections, R126638 showed superior antifungal activity. R126638 inhibits ergosterol synthesis in Candida albicans, Trichophyton mentagrophytes, Trichophyton rubrum, and Microsporum canis
American Society for Microbiology.
-
35. Detection of Cryptococcus neoformans DNA in Tissue Samples by Nested and Real-Time PCR Assays
Two PCR protocols targeting the 18S rRNA gene of Cryptococcus neoformans were established, compared, and evaluated in murine cryptococcal meningitis. One protocol was designed as a nested PCR to be performed in conventional block thermal cyclers. The other protocol was designed as a quantitative single-round PCR adapted to LightCycler technology. One hundred
American Society for Microbiology.